Please enable JavaScript to continue using this application.

Compare $CRBP vs $VXRT | Chartloom

Compare

$CRBP vs $VXRT

Corbus Pharmaceuticals Holdings Inc · Vaxart Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

VXRT

Vaxart Inc

Compare $CRBP vs $VXRT

Comparing Corbus Pharmaceuticals Holdings Inc and Vaxart Inc

CRBPCorbus Pharmaceuticals Holdings Inc

VXRTVaxart Inc

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

VXRTVaxart Inc

Market cap

$105M

P/E (TTM)

2.73x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

201.1%

YTD performance

19.2%

52W performance

26.5%

FCF yield

31.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBP

VXRT

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

VXRT

Vaxart Inc

Market Cap

CRBP$100M

VXRT$105M

Enterprise Value

CRBP$76M

VXRT$62M

Price

CRBP$5.38

VXRT$0.43

P/E Ratio

CRBPN/A

VXRT2.73x

P/S Ratio

CRBP76.49x

VXRT0.43x

EV/Sales

CRBP61.41x

VXRT0.25x

EV/EBITDA

CRBP0.00x

VXRT1.01x

P/B Ratio

CRBP1.16x

VXRT1.27x

P/FCF Ratio

CRBPN/A

VXRT3.15x

EV/FCF

CRBP-0.88x

VXRT1.85x

PEG Ratio

CRBPN/A

VXRTN/A

Forward P/E (NTM)

CRBPN/A

VXRTN/A

Forward P/S (NTM)

CRBPN/A

VXRTN/A

Revenue (TTM)

CRBP$0

VXRT$243M

Revenue Growth (YoY)

CRBPN/A

VXRT201.1%

Forward Rev Growth

CRBP116.0%

VXRT-98.8%

Gross Margin (TTM)

CRBP0.0%

VXRT100.0%

Operating Margin (TTM)

CRBP0.0%

VXRT16.3%

EBITDA Margin (TTM)

CRBP0.0%

VXRT18.8%

Net Margin (TTM)

CRBP0.0%

VXRT15.9%

FCF Margin (TTM)

CRBPN/A

VXRT13.7%

Net Income (TTM)

CRBP$-102M

VXRT$39M

FCF (TTM)

CRBP$-87M

VXRT$33M

EPS (TTM)

CRBP-$5.25

VXRT$0.16

ROE (TTM)

CRBP-8705.0%

VXRT53.0%

ROA (TTM)

CRBP-7422.0%

VXRT20.8%

ROIC (TTM)

CRBP-8705.0%

VXRT50.2%

Cash

CRBP$23M

VXRT$48M

Debt

CRBP$0

VXRT$5M

Net Cash/Debt

CRBP$23M

VXRT$43M

Current Ratio (TTM)

CRBP5.71x

VXRT1.60x

Quick Ratio (TTM)

CRBP5.62x

VXRT1.52x

Debt/Equity (TTM)

CRBP0.00x

VXRT0.06x

Debt/Assets (TTM)

CRBP0.0%

VXRT0.0%

Interest Coverage (TTM)

CRBPN/A

VXRTN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

VXRT0.00x

Beta

CRBP2.74

VXRT1.23

52W Performance

CRBP-59.9%

VXRT26.5%

YTD Performance

CRBP-31.6%

VXRT19.2%

% from 52W High

CRBP-73.8%

VXRT-48.6%

% from 52W Low

CRBP4.9%

VXRT42.4%

Asset Turnover (TTM)

CRBP0.01x

VXRT1.31x

FCF Yield (TTM)

CRBP-87.0%

VXRT31.8%

Earnings Yield (TTM)

CRBP-102.2%

VXRT36.7%

Dividend Yield (TTM)

CRBPN/A

VXRTN/A

Rule of 40

CRBP0.0

VXRT214.8

EV/GP/RG

CRBPN/A

VXRTN/A

Ticker research

View CRBP research View VXRT research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$100M	$105M
Enterprise Value	$76M	$62M
Price	$5.38	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	76.49x	0.43x
EV/Sales	61.41x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	1.16x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	-0.88x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$243M
Revenue Growth (YoY)	N/A	201.1%
Forward Rev Growth	116.0%	-98.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	0.0%	18.8%
Net Margin (TTM)	0.0%	15.9%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-102M	$39M
FCF (TTM)	$-87M	$33M
EPS (TTM)	-$5.25	$0.16
ROE (TTM)	-8705.0%	53.0%
ROA (TTM)	-7422.0%	20.8%
ROIC (TTM)	-8705.0%	50.2%
Financial Health
Cash	$23M	$48M
Debt	$0	$5M
Net Cash/Debt	$23M	$43M
Current Ratio (TTM)	5.71x	1.60x
Quick Ratio (TTM)	5.62x	1.52x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	1.23
52W Performance	-59.9%	26.5%
YTD Performance	-31.6%	19.2%
% from 52W High	-73.8%	-48.6%
% from 52W Low	4.9%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.31x
FCF Yield (TTM)	-87.0%	31.8%
Earnings Yield (TTM)	-102.2%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	214.8
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View VXRT research

Valuation

P/E Ratio

VXRT

2.73x

P/S Ratio

VXRT

0.43x

CRBP

76.49x

EV/FCF

CRBP

-0.88x

VXRT

1.85x

Growth & revenue

Revenue Growth TTM

VXRT

201.1%

Forward Revenue Growth

CRBP

116.0%

VXRT

-98.8%

Profitability & performance

Gross Margin

VXRT

100.0%

CRBP

0.0%

ROE

VXRT

53.0%

CRBP

-8705.0%

FCF Yield %

VXRT

31.8%

CRBP

-87.0%

52-Week Performance

VXRT

26.5%

CRBP

-59.9%

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

VXRT

Vaxart Inc

Market Cap

CRBP$100M

VXRT$105M

Enterprise Value

CRBP$76M

VXRT$62M

Price

CRBP$5.38

VXRT$0.43

P/E Ratio

CRBPN/A

VXRT2.73x

P/S Ratio

CRBP76.49x

VXRT0.43x

EV/Sales

CRBP61.41x

VXRT0.25x

EV/EBITDA

CRBP0.00x

VXRT1.01x

P/B Ratio

CRBP1.16x

VXRT1.27x

P/FCF Ratio

CRBPN/A

VXRT3.15x

EV/FCF

CRBP-0.88x

VXRT1.85x

PEG Ratio

CRBPN/A

VXRTN/A

Forward P/E (NTM)

CRBPN/A

VXRTN/A

Forward P/S (NTM)

CRBPN/A

VXRTN/A

Revenue (TTM)

CRBP$0

VXRT$243M

Revenue Growth (YoY)

CRBPN/A

VXRT201.1%

Forward Rev Growth

CRBP116.0%

VXRT-98.8%

Gross Margin (TTM)

CRBP0.0%

VXRT100.0%

Operating Margin (TTM)

CRBP0.0%

VXRT16.3%

EBITDA Margin (TTM)

CRBP0.0%

VXRT18.8%

Net Margin (TTM)

CRBP0.0%

VXRT15.9%

FCF Margin (TTM)

CRBPN/A

VXRT13.7%

Net Income (TTM)

CRBP$-102M

VXRT$39M

FCF (TTM)

CRBP$-87M

VXRT$33M

EPS (TTM)

CRBP-$5.25

VXRT$0.16

ROE (TTM)

CRBP-8705.0%

VXRT53.0%

ROA (TTM)

CRBP-7422.0%

VXRT20.8%

ROIC (TTM)

CRBP-8705.0%

VXRT50.2%

Cash

CRBP$23M

VXRT$48M

Debt

CRBP$0

VXRT$5M

Net Cash/Debt

CRBP$23M

VXRT$43M

Current Ratio (TTM)

CRBP5.71x

VXRT1.60x

Quick Ratio (TTM)

CRBP5.62x

VXRT1.52x

Debt/Equity (TTM)

CRBP0.00x

VXRT0.06x

Debt/Assets (TTM)

CRBP0.0%

VXRT0.0%

Interest Coverage (TTM)

CRBPN/A

VXRTN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

VXRT0.00x

Beta

CRBP2.74

VXRT1.23

52W Performance

CRBP-59.9%

VXRT26.5%

YTD Performance

CRBP-31.6%

VXRT19.2%

% from 52W High

CRBP-73.8%

VXRT-48.6%

% from 52W Low

CRBP4.9%

VXRT42.4%

Asset Turnover (TTM)

CRBP0.01x

VXRT1.31x

FCF Yield (TTM)

CRBP-87.0%

VXRT31.8%

Earnings Yield (TTM)

CRBP-102.2%

VXRT36.7%

Dividend Yield (TTM)

CRBPN/A

VXRTN/A

Rule of 40

CRBP0.0

VXRT214.8

EV/GP/RG

CRBPN/A

VXRTN/A

Ticker research

View CRBP research View VXRT research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$100M	$105M
Enterprise Value	$76M	$62M
Price	$5.38	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	76.49x	0.43x
EV/Sales	61.41x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	1.16x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	-0.88x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$243M
Revenue Growth (YoY)	N/A	201.1%
Forward Rev Growth	116.0%	-98.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	0.0%	18.8%
Net Margin (TTM)	0.0%	15.9%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-102M	$39M
FCF (TTM)	$-87M	$33M
EPS (TTM)	-$5.25	$0.16
ROE (TTM)	-8705.0%	53.0%
ROA (TTM)	-7422.0%	20.8%
ROIC (TTM)	-8705.0%	50.2%
Financial Health
Cash	$23M	$48M
Debt	$0	$5M
Net Cash/Debt	$23M	$43M
Current Ratio (TTM)	5.71x	1.60x
Quick Ratio (TTM)	5.62x	1.52x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	1.23
52W Performance	-59.9%	26.5%
YTD Performance	-31.6%	19.2%
% from 52W High	-73.8%	-48.6%
% from 52W Low	4.9%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.31x
FCF Yield (TTM)	-87.0%	31.8%
Earnings Yield (TTM)	-102.2%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	214.8
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View VXRT research